---

---

symbols : Nvo    crawled time : 22:00   

save search

---

Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published: 2024-01-17 (Crawled : 22:00) - prnewswire.com
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 18.26% | O: -0.36% H: 1.32% C: 1.18%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -7.57% | O: -0.21% H: 0.0% C: 0.0%
VRTX | $400.76 -1.03% -1.06% 810K |

Health Technology

| -7.61% | O: -0.5% H: 0.76% C: 0.32%
EDIT | News | $5.35 -2.02% -1.96% 210 |

Health Technology

| -36.39% | O: 0.83% H: 0.35% C: -3.66%
AGIO | $31.67 -0.44% -0.44% 0 |

Health Technology

| 45.88% | O: 0.41% H: 0.0% C: -2.2%
crispr companies therapeutics growth study market

---

Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -9.7% | O: 1.1% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 16.09% | O: -0.33% H: 0.35% C: -1.5%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 19.36% | O: 0.67% H: 0.85% C: 0.21%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -8.72% | O: 0.69% H: 0.0% C: 0.0%
ALDX | $3.94 0.77% 0.51% 530K |

Health Technology

| 17.96% | O: -1.8% H: 0.46% C: -2.44%
companies therapeutics growth market

---

Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published: 2023-11-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 6.41% | O: 3.37% H: 1.29% C: 1.29%
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 30.83% | O: 2.62% H: 0.67% C: 0.58%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 23.21% | O: -3.12% H: 0.61% C: -0.46%
VRTX | $400.76 -1.03% -1.06% 810K |

Health Technology

| 14.72% | O: 0.4% H: 0.38% C: -2.2%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 4.6% | O: 1.54% H: 0.0% C: 0.0%
companies diabetes study market

---

Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published: 2023-10-25 (Crawled : 22:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.23% 690 |

Health Technology

| -8.76% | O: -4.69% H: 0.69% C: -3.18%
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 29.49% | O: -1.47% H: 0.22% C: -0.83%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -2.26% | O: 0.1% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -10.63% | O: 0.09% H: 0.0% C: 0.0%
bleeding expected reach disorders treatment global market

---

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -7.31% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -8.36% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 18.53% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.23% 690 |

Health Technology

| -16.74% | O: 1.32% H: 0.31% C: 0.12%
PFE | News 4 | $26.27 -0.19% -0.38% 130K |

Health Technology

| -30.9% | O: 0.6% H: 1.07% C: 0.29%
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| -20.14% | O: -1.84% H: 1.62% C: 1.33%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 1.28% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| -24.46% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -5.56% | O: 1.05% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| -2.25% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

---

Bi-Specific MAbS Global Market Report 2023: Major Players Include Johnson & Johnson, Novartis, Hoffmann-La Roche, Novo Nordisk and Bayer
Published: 2023-05-16 (Crawled : 22:00) - prnewswire.com
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| -24.75% | O: 0.49% H: 0.02% C: -0.82%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -4.34% | O: -0.51% H: 0.0% C: -1.05%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -7.03% | O: 0.28% H: 0.17% C: -0.5%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 12.04% | O: 0.25% H: 0.03% C: -1.15%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -12.53% | O: -0.73% H: 0.0% C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 19.8% | O: -0.82% H: 0.03% C: -0.44%
report global market

---

Terns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 14.28% | O: 0.35% H: 0.22% C: -0.42%

---

Ozempic® 2.0 mg approved in the US for the treatment of type 2 diabetes
Published: 2022-03-28 (Crawled : 22:00) - globenewswire.com
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 16.91% | O: 2.86% H: 0.47% C: -0.72%
ozempic treatment diabetes

---

GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH
Published: 2021-11-18 (Crawled : 22:00) - globenewswire.com
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 9.68% | O: -0.36% H: 0.3% C: -0.65%
ICPT | $19.0 -0.05% 4M |

Health Technology

| 8.55% | O: -1.54% H: 2.15% C: 0.06%
GILD | $67.08 0.08% 0.06% 2.5K |

Health Technology

| -1.05% | O: 0.59% H: 1.04% C: 0.74%
GNFT | $3.49 1.31% -6.4% 0 |

Health Technology

| 4.18% | O: 5.07% H: 1.14% C: -0.27%
AMGN | News | $273.01 -0.19% -0.17% 400 |

Health Technology

| 33.82% | O: 0.61% H: 0.45% C: 0.39%
nis4 unique risk technology nash

---

Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021
Published: 2021-11-05 (Crawled : 22:00) - globenewswire.com
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| Email alert Add to watchlist

---

Worldwide Menopause Industry to 2026 - Prevalence of Herbal Treatment for Menopause Presents Opportunities
Published: 2021-11-04 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| -4.98% | O: 3.11% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 15.45% | O: -0.18% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 8.9% | O: -3.06% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 17.52% | O: -0.42% H: 0.38% C: 0.37%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| -4.91% | O: 0.05% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 182.52% | O: 1.03% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 43.35% | O: -0.28% H: 0.51% C: 0.39%
treatment

---

Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 36.24% | O: -0.44% H: 0.89% C: 0.88%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 207.41% | O: 0.43% H: 0.88% C: 0.35%
ALNY | $143.8 -1.55% -1.58% 50 |

Health Technology

| -20.81% | O: -1.81% H: 0.94% C: -0.19%
financial results results

---

Dicerna to Participate in 42nd Annual Goldman Sachs Global Healthcare Conference
Published: 2021-06-03 (Crawled : 22:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 60.0% | O: -0.05% H: 1.1% C: 1.1%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 277.75% | O: -0.07% H: 2.34% C: 1.86%
ALNY | $143.8 -1.55% -1.58% 50 |

Health Technology

| 0.67% | O: -0.72% H: 4.77% C: 3.86%
conference

---

Outcome of Innate Pharma’s Annual General Meeting
Published: 2021-05-28 (Crawled : 22:00) - globenewswire.com
IPHA | $2.46 3.8% 4.05% 0 |

Health Technology

| Email alert Add to watchlist
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| Email alert Add to watchlist
pharma

---

Novo Nordisk receives Refusal to File letter for once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Published: 2021-03-22 (Crawled : 22:00) - globenewswire.com
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 77.57% | O: -2.35% H: 0.49% C: -2.0%
diabetes treatment

---

Alligator Bioscience appoints Søren Bregenholt as new CEO
Published: 2021-03-18 (Crawled : 22:00) - biospace.com/
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 75.76% | O: -1.43% H: 0.99% C: 0.23%
APVO | $0.6826 -7.28% -7.84% 2.2K |

Health Technology

| -98.17% | O: -2.29% H: 1.3% C: -4.98%
new ceo ceo leo bioscience

---

Gainers vs Losers

49%

51%

Top 10 Gainers

TRMK 4 | $29.89 1.81% 2.7K |

Finance

TSHA | $2.375 1.06% 19K |

Health Technology

TSN | $61.57 0.41% 14K |

Consumer Non-Durables

TMUS S | $164.61 0.26% 190K |

Communications

TTEC 4 | $8.02 1.5K |

Commercial Services

TRMB S | $59.26 -0.42% 9.8K |

Electronic Technology

AMED | $90.65 -0.44% 3.1K |

Health Services

TRS 4 | $26.08 -0.76% 1K |

Producer Manufacturing

TRV | $211.8 -0.76% 21K |

Finance

TT | $294.15 -0.79% 21K |

Producer Manufacturing

---

Your saved searches

---